The Swedish company that commercialized the first bio-based ink in 2016 has moved far beyond bioprinting and on-demand biofabrication of human organs and tissues, after completing six acquisitions of companies in other life-sciences specialties this year thus far. CELLINK Life Sciences has been renamed BICO Group. BICO is short for “bioconvergence,” the combination of biology, engineering and computer science technologies for healthcare and life-sci applications . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

The post Buying Spree: Rebranded BICO Bets Big on “Bioconvergence” appeared first on GEN – Genetic Engineering and Biotechnology News.